Medicines
Shortlist up to four to read them side by side.
704 medicine recalls FDA’s Enforcement Report published in 2026, the newest year, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
704of 704 medicine recallsshown with your filters
The list
- Medicine recall Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar Failed Content Uniformity Specifications. Class IIFDA’s classSep 23, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 23, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle Failed Dissolution Specifications Class IIFDA’s classSep 23, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 23, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Dopamine HCl Inj., USP, 200 mg/5 mL Lack of Assurance of Sterility Class IIFDA’s classSep 23, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 23, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Thyroid Tablets, USP, 1/2 Grain Superpotent Drug FDA Class I, its most serious class Class IFDA’s class (needs attention)Sep 23, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 23, 2026ClassClass IStatusOngoingWhereNationwide
- Medicine recall Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL per dropper bottle, For Office Use… Subpotent Drug Class IIIFDA’s classSep 16, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 16, 2026ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Class IIIFDA’s classSep 16, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 16, 2026ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall Dextrose Injection, USP, 70 %, 2000 mL bags Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution. FDA Class I, its most serious class Class IFDA’s class (needs attention)Sep 16, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 16, 2026ClassClass IStatusOngoingWhereNationwide
- Medicine recall fentaNYL Citrate, 1,000 mcg/100 mL Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product… Class IIFDA’s classSep 16, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 16, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Epinephrine Injection, USP, 30 mg/30 mL Presence of Particulate Matter and Lack of Assurance of Sterility. FDA Class I, its most serious class Class IFDA’s class (needs attention)Sep 16, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 16, 2026ClassClass IStatusOngoingWhereNationwide
- Medicine recall 0.9% Sodium Chloride Injection, USP, 100 mL Partial Fill Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene FDA Class I, its most serious class Class IFDA’s class (needs attention)Sep 16, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 16, 2026ClassClass IStatusOngoingWhereNationwide
- Medicine recall Vancomycin Injection, USP CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall MYXREDLIN, Insulin Human CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single… CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Clindamycin Injection USP CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Dexmedetomidine Hydrochloride CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose… CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Pantoprazole Sodium CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall CARDENE IV (Nicardipine Hydrochloride) CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Nexterone (amiodarone HCI), 360 mg/200 mL CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Clindamycin Injection USP CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Clindamycin Phosphate CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Clindamycin Injection USP CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Clindamycin Injection USP CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose… CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Vancomycin Injection, USP CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL… CGMP Deviations Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide, and Puerto Rico named
- Medicine recall Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle Presence of Foreign Tablets/Capsules Class IIIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 50ML… Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label. Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 3ml -… Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label. Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 20ml… Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label. Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 90ml… Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label. Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Broadway Joe’s Pain Cream, (Histamine Dihydrochloride 0.025%), 1500mg CBD Isolate, 1000mg Hempseed oil, 2… CGMP Deviations: Potential contamination of raw material Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportColoradothe one state its words name PublishedSep 9, 2026ClassClass IIStatusOngoingWhereColorado
- Medicine recall Broadway Joe’s Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, HempSeed Oil… CGMP Deviations: Potential contamination of raw material Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportColoradothe one state its words name PublishedSep 9, 2026ClassClass IIStatusOngoingWhereColorado
- Medicine recall Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials Failed Dissolution Specifications Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules Failed dissolution specifications. Class IIIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall traZODone Hydrochloride Tablets, USP, 50 mg Presence of Foreign Tablets/Capsules Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall 2% Chlorhexidine Gluconate* Cloth, Non-sterile, 6 Disposable cloths, Sage Products LLC, 3909 Three Oaks Road,… Cross Contamination with Other Products Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL Failed Stability Specifications: Out of specification stability result for the protein concentration profile. Class IIIFDA’s classSep 9, 2026in FDA’s Enforcement Report2 statesnamed in where it went PublishedSep 9, 2026ClassClass IIIStatusOngoingWhereMissouri and Tennessee
- Medicine recall Prasugrel Tablets, USP, 10mg Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets Labeling: Label Mix-up Class IIIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle Failed Dissolution Specifications. Class IIFDA’s classSep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case Presence of particulate matter: Particulates identified as fiberglass FDA Class I, its most serious class Class IFDA’s class (needs attention)Sep 9, 2026in FDA’s Enforcement ReportNot namedno state, in where it went PublishedSep 9, 2026ClassClass IStatusOngoingWhereNo state named
- Medicine recall Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutathione, Ascorbic Acid, Benzyl… Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin. FDA Class I, its most serious class Class IFDA’s class (needs attention)Sep 9, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 9, 2026ClassClass IStatusOngoingWhereNationwide
- Medicine recall Levothyroxine Sodium Tablets, USP, 25 mcg Subpotent Drug Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Levothyroxine Sodium Tablets, USP, 50 mcg Subpotent Drug Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Levothyroxine Sodium Tablets, USP, 75 mcg Subpotent Drug Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Levothyroxine Sodium Tablets, USP, 88 mcg Subpotent Drug Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.